Neurocognitive effects of antipsychotic medications in patients with chronic schizophrenia in the CATIE Trial. [electronic resource]
Producer: 20070703Description: 633-47 p. digitalISSN:- 0003-990X
- Adult
- Antipsychotic Agents -- therapeutic use
- Benzodiazepines -- therapeutic use
- Cognition Disorders -- diagnosis
- Cohort Studies
- Dibenzothiazepines -- therapeutic use
- Double-Blind Method
- Female
- Humans
- Male
- Neuropsychological Tests -- statistics & numerical data
- Olanzapine
- Perphenazine -- therapeutic use
- Piperazines -- therapeutic use
- Quetiapine Fumarate
- Risperidone -- therapeutic use
- Schizophrenia -- diagnosis
- Schizophrenic Psychology
- Thiazoles -- therapeutic use
- Treatment Outcome
No physical items for this record
Publication Type: Comparative Study; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.